Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective

por Atallah, Ehab L., Maegawa, Rodrigo, Latremouille-Viau, Dominick, Rossi, Carmine, Guérin, Annie
Publicado 2022

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States

por Atallah, Ehab L., Maegawa, Rodrigo, Latremouille-Viau, Dominick, Rossi, Carmine, Guérin, Annie, Wu, Eric Q., Patwardhan, Pallavi
Publicado 2022